Randhawa Simrat

CIK 00019922601 companyNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001992260

Recent Transactions

30 trades

Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-12−12,500→ 106,250 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-12$8.44/sh+7,998→ 7,998 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-12$17.88/sh+5,000→ 12,998 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-12$21.77/sh+8,332→ 21,330 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-12−8,332→ 54,174 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-12−5,000→ 71,184 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-03-12−7,998→ 3,998 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-12$81.48/sh−33,830→ 0 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2026-03-12$22.07/sh+12,500→ 33,830 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2026-02-03+150,000→ 150,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-11-14−31,250→ 118,750 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-11-14−37,494→ 62,506 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-14$17.88/sh+40,287→ 44,287 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-14$38.14/sh−109,031→ 4,000 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-14$21.77/sh+37,494→ 81,781 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-11-14−40,287→ 76,184 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-14$22.07/sh+31,250→ 113,031 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-13$37.72/sh−18,576→ 4,000 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-13$37.04/sh−42,765→ 22,576 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-13$17.88/sh+3,529→ 91,507 total
Sale
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-13$35.80/sh−26,166→ 65,341 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-11-13−3,529→ 116,471 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2025-11-13$8.44/sh+83,978→ 87,978 total
Exercise/Conversion
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-11-13−83,978→ 11,996 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-09-23+60,000→ 60,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-02-03+150,000→ 150,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-05-23+100,000→ 100,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-01-24+120,000→ 120,000 total
Purchase
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2023-09-22$13.20/sh+2,000→ 4,000 total
Purchase
Dianthus Therapeutics, Inc. /DE/$DNTH
Common Stock
2023-09-21$13.20/sh+2,000→ 2,000 total

Companies

Dianthus Therapeutics, Inc. /DE/
EVP, Head of R&D
$DNTH

Recent Filings

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036

View on SEC.gov